EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cryo-Cell International's Enterprise Value is $70.31 Mil.
Cryo-Cell International's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-12.76 Mil. Therefore, Cryo-Cell International's EV-to-EBIT for today is -5.51.
The historical rank and industry rank for Cryo-Cell International's EV-to-EBIT or its related term are showing as below:
CCEL'
s EV-to-EBIT Range Over the Past 10 Years
Min: -94.75 Med: 11.9 Max: 36.78
Current: -5.51
During the past 13 years, the highest EV-to-EBIT of Cryo-Cell International was 36.78. The lowest was -94.75. And the median was 11.90.
CCEL's EV-to-EBIT is ranked worse than 100% of 428
companies
in the Healthcare Providers & Services industry
Industry Median: 18.24
vs CCEL: -5.51
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cryo-Cell International's Enterprise Value for the quarter that ended in Feb. 2024 was $53.50 Mil.
Cryo-Cell International's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-12.76 Mil. Cryo-Cell International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was -23.85%.
Cryo-Cell International EV-to-EBIT Historical Data
The historical data trend for Cryo-Cell International's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cryo-Cell International Annual Data
Trend
Nov14
Nov15
Nov16
Nov17
Nov18
Nov19
Nov20
Nov21
Nov22
Nov23
EV-to-EBIT
11.43
7.96
25.17
9.72
-4.47
Cryo-Cell International Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
EV-to-EBIT
8.11
10.67
11.66
-4.47
-4.19
Competitive Comparison
For the Medical Care Facilities subindustry, Cryo-Cell International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International EV-to-EBIT Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's EV-to-EBIT falls into.
Cryo-Cell International EV-to-EBIT Calculation
Cryo-Cell International's EV-to-EBIT for today is calculated as:
Cryo-Cell International's current Enterprise Value is $70.31 Mil.
Cryo-Cell International's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (AMEX:CCEL) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cryo-Cell International's Enterprise Value for the quarter that ended in Feb. 2024 was $53.50 Mil.
Cryo-Cell International's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 